23 Nov 2022
A template of protocol for use of Macimorelin for the diagnosis of adult GHD and the associated patient information leaflet are now available on the Society for Endocrinology (SfE) resource page which can be accessed by all SfE members.
An expert panel chaired by Márta Korbonits and Sherwin Criseno developed a protocol and patient info leaflet for the use of the new dynamic stimulation test macimorelin in the diagnosis of adult GHD. The protocol and PIL can be used as a template and adapt according to each organisation’s requirement and process. Copy of the protocol and PIL can be found on SfE Resource hub here.
Migraines and menopause symptoms linked to cardiovascular disease risk
19 Apr 2024
Risk of postpartum depression associated with stress during adolescence
19 Apr 2024
Surgery for hypoparathyroidism sees reduced facture rates
19 Apr 2024
Patients with type 2 diabetes taking antidepressants have a higher mortality risk
19 Apr 2024
Endocrine-disrupting chemical levels found at alarming levels in Australia
11 Apr 2024